AU3385900A - Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives - Google Patents

Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives

Info

Publication number
AU3385900A
AU3385900A AU33859/00A AU3385900A AU3385900A AU 3385900 A AU3385900 A AU 3385900A AU 33859/00 A AU33859/00 A AU 33859/00A AU 3385900 A AU3385900 A AU 3385900A AU 3385900 A AU3385900 A AU 3385900A
Authority
AU
Australia
Prior art keywords
agonist
dito
naturally
bone volume
increasing bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33859/00A
Inventor
Mitchell Anthony Delong
James Richard Hartke
Mark Walden Lundy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU3385900A publication Critical patent/AU3385900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
AU33859/00A 1999-03-05 2000-03-01 Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives Abandoned AU3385900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12292199P 1999-03-05 1999-03-05
US60122921 1999-03-05
PCT/US2000/005161 WO2000051616A1 (en) 1999-03-05 2000-03-01 Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives

Publications (1)

Publication Number Publication Date
AU3385900A true AU3385900A (en) 2000-09-21

Family

ID=22405645

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33859/00A Abandoned AU3385900A (en) 1999-03-05 2000-03-01 Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives

Country Status (3)

Country Link
AU (1) AU3385900A (en)
CO (1) CO5150204A1 (en)
WO (1) WO2000051616A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002538105A (en) * 1999-03-05 2002-11-12 ザ プロクター アンド ギャンブル カンパニー Use of a non-naturally occurring EP1 selective agonist for increasing bone volume
US20110038884A1 (en) 2008-04-28 2011-02-17 National University Co., Hamamatsu Univer. School Of Medicine Immunopotentiating agent comprising ep1 agonist

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3982016A (en) * 1975-08-06 1976-09-21 Pfizer Inc. Bone deposition by 16-aryl-13,14-dihydro-PGE2 p-biphenyl esters
US4621100A (en) * 1981-09-25 1986-11-04 The Upjohn Company Treatment of osteoporosis with prostaglandins
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
DE69613693T2 (en) * 1995-05-18 2002-05-16 Allergan Sales Inc 2-HETEROARYLALKENYL DERIVATIVES OF CYCLOPENTANO-HEPTANE (HEPTAEN) ACID AS A THERAPEUTIC AGENT FOR TREATING THE INCREASED EYE PRESSURE
US5741810A (en) * 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
US6156799A (en) * 1997-09-09 2000-12-05 The Procter & Gamble Company Method of increasing bone volume using non-naturally-occurring FP selective agonists

Also Published As

Publication number Publication date
WO2000051616A1 (en) 2000-09-08
CO5150204A1 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
AU4422800A (en) Method of analysis of medical signals
AU1345700A (en) Method of sterilizing females
AU4020300A (en) Method and apparatus of a strong metal-ceramic braze bond
AU5173800A (en) Method and apparatus for mapping bits to an information burst
AU2237399A (en) Method of cleaning a well bore prior to cementing
ZA988228B (en) Method of increasing bone volume using non-naturally-occurring FP selective agonists
AU2701801A (en) Method and system for measuring heart rate variability
AU2003285747A1 (en) System and method for determination of fetal movement
EP0950424A3 (en) Method of manufacture for reinforced medical tubings
AU3385900A (en) Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives
AU2222499A (en) Method of synthesis of derivatives of aloesin
IL145128A0 (en) Method of increasing bone volume using non-naturally-occurring ep1 selective agonists
AU2001212603A1 (en) Method for management of blood glucose levels
AU2003239156A1 (en) System and method of annotating network packets
AU2001294173A1 (en) Method of screening physiologically active substance
AU6134399A (en) Method for re-perfusion of oxygenated blood
AU2003242973A1 (en) System and method for determining properties of a tubular cavity
PL338742A1 (en) Method of obtaining derivatives of dioxypenicillanic acid
AU2003302116A1 (en) Method of preparation of derivatives of substituted 2-aryl aikanoic acids
AU2001232321A1 (en) Dioxin derivatives and method of measurement therewith
AU2003274159A1 (en) Method of obtaining dodecalactam using solid catalysts
AU2000246994A1 (en) Method of using hinged connector for steel trusses
AU2002360193A1 (en) System and method for web to mainframe synchronization
PL340733A1 (en) Method of obtaining derivatives of 2-aminothiazocarboxamide
AU5988600A (en) Method for continuous monitoring of cardiac output

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase